Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Science Translational Medicine, 2023
Additive efficacy of a bispecific anti–TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis

Biesemann N., Margerie D., Asbrand C. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationCell Culture Supernatant

Journal of Hypertension, 2023
Associations of childhood adiposity with adult intima–media thickness and inflammation: a 20-year longitudinal population-based cohort

Fujikawa T., Kobayashi M., Wagner S. et al.

Olink Target 96CVDMetabolic DiseasesPathophysiologyPlasma

Cell Reports Medicine, 2023
Multiplex immune profiling reveals the role of serum immune proteomics in predicting response to preoperative chemotherapy of gastric cancer

Tang Z., Gu Y., Shi Z. et al.

Olink Target 96OncologyPatient StratificationSerum

Journal of Clinical Investigation, 2023
Single-cell characterization of anti–LAG-3 and anti–PD-1 combination treatment in patients with melanoma

Huuhtanen J., Kasanen H., Peltola K. et al.

Olink Target 96OncologyImmunotherapyPathophysiologySerum

Journal of Virology, 2023
Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction

Duran-Castells C., Llano A., Kawana-Tachikawa A. et al.

Olink Target 96Infectious DiseasesPatient StratificationPlasmaCSF

Biomarker Research, 2023
Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1

Campbell K., Cawley N., Luke R. et al.

Olink Explore 3072/384NeurologyPatient StratificationCSF

Immunity & Ageing, 2023
Mitochondrial DNA and inflammatory proteins are higher in extracellular vesicles from frail individuals

Byappanahalli A., Noren Hooten N., Vannoy M. et al.

Olink Target 96AgingPathophysiologyEV Lysate

Clinical Chemistry and Laboratory Medicine (CCLM), 2023
Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood

Andreasson U., Gobom J., Delatour V. et al.

Olink Target 96NeurologyTechnical EvaluationPlasmaSerum

JID Innovations, 2023
Modulation of Inflammatory Proteins in Serum May Reflect Cutaneous Immune Responses in Cancer Immunotherapy

Han J., Correa da Rosa J., Agarwal A. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationSerumTissue Lysate

Blood, 2023
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease

Penter L., Liu Y., Wolff J. et al.

OncologyImmunotherapyPathophysiologySerum

PLOS ONE, 2023
Proteomics biomarker discovery for individualized prevention of familial pancreatic cancer using statistical learning

Ha C., Müller-Nurasyid M., Petrera A. et al.

Olink Target 96OncologyData ScienceSerum

ERJ Open Research, 2023
Cardiovascular disease-linked plasma proteins are mainly associated with lung volume

Rydell A., Nerpin E., Zhou X. et al.

Olink Target 96Respiratory DiseasesCVDPathophysiologyPlasma

Translational Neurodegeneration, 2023
Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

Yulug B., Altay O., Li X. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Molecular Medicine, 2023
Urine-based multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS

Batra R., Uni R., Akchurin O. et al.

Olink Target 96Respiratory DiseasesInfectious DiseasesPathophysiologyPatient StratificationUrine

European Journal of Vascular and Endovascular Surgery, 2023
Plasma Lipoprotein Lipase Is Associated with Risk of Future Major Adverse Cardiovascular Events in Patients Following Carotid Endarterectomy

Mekke J., Verwer M., Stroes E. et al.

Olink Target 96CVDPatient StratificationPlasma

Journal of the American Heart Association, 2023
High Plasma Levels of Soluble Lectin‐like Oxidized Low‐Density Lipoprotein Receptor‐1 Are Associated With Inflammation and Cardiometabolic Risk Profiles in Pediatric Overweight and Obesity

Stinson S., Jonsson A., Andersen M. et al.

Olink Target 96Metabolic DiseasesCVDPatient StratificationPlasma

Clinical Proteomics, 2023
Are the results from a multiplex proteomic assay and a conventional immunoassay for NT-proBNP and GDF-15 comparable?

Skau E., Wagner P., Leppert J. et al.

Olink Target 96CVDTechnical EvaluationPlasma

BMC Medicine, 2023
Starch intake, amylase gene copy number variation, plasma proteins, and risk of cardiovascular disease and mortality

Li H., Borné Y., Wang Y. et al.

Olink Target 96CVDNutritional SciencePatient StratificationPlasma

European Journal of Preventive Cardiology, 2023
Proteomic profiling identifies novel independent relationships between inflammatory proteins and myocardial infarction

Valdes-Marquez E., Clarke R., Hill M. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Med, 2023
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors

Nuñez N., Berner F., Friebel E. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationPlasma

1945 publications